Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant
|ClinicalTrials.gov Identifier: NCT00281814|
Recruitment Status : Completed
First Posted : January 25, 2006
Last Update Posted : January 26, 2018
RATIONALE: Questionnaires that measure coping may improve the ability to plan supportive care for patients undergoing donor bone marrow transplant.
PURPOSE: This clinical trial is studying coping in patients who are undergoing a donor bone marrow transplant.
|Condition or disease||Intervention/treatment|
|Chronic Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Psychosocial Effects of Cancer and Its Treatment||Procedure: psychosocial assessment and care|
- Investigate the relative importance of having a consistent inpatient lay care-partner for patients undergoing allogeneic bone marrow transplantation, in terms of the effects on modes of adjustment to illness and survival.
OUTLINE: Patients undergo a 40-minute recorded oral interview in person to provide personal and social demographic data using a 20-item questionnaire (The Adjustment to Illness Questionnaire-Bone Marrow Transplantation) at baseline (pre-transplant) and at day 100 post-transplant.
PROJECTED ACCRUAL: A total of 40 patients will be accrued for this study.
|Study Type :||Observational|
|Actual Enrollment :||36 participants|
|Official Title:||Adjustment to Illness by Survival Rates in Allogeneic Bone Marrow Transplant (BMT): The Relative Importance of Lay Care-Partner Support|
|Actual Study Start Date :||February 1, 2006|
|Primary Completion Date :||December 31, 2008|
|Study Completion Date :||January 4, 2017|
Procedure: psychosocial assessment and care
- Compare modes of illness adjustment, presence or absence of an inpatient lay care-partner, and survival rates [ Time Frame: Through 100 days post transplant ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00281814
|United States, Ohio|
|Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|
|Cleveland, Ohio, United States, 44195|
|Study Chair:||Brian J. Bolwell, MD||Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center|